Robotic Wedge Resection for Unfavorably Located Gastric Gastrointestinal Stromal Tumors: Perioperative and Long-Term Oncological Outcomes

2020 ◽  
Author(s):  
Simone Di Maria Grimaldi ◽  
Alessandra Marano ◽  
Luca Pellegrino ◽  
Paolo Geretto ◽  
Silvia Palagi ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumors ◽  
Wedge Resection ◽  
Stromal Tumors ◽  
Oncological Outcomes

Long-term and surgical outcomes of laparoscopic surgery for gastric gastrointestinal stromal tumors

2014 ◽  
Vol 28 (8) ◽  
pp. 2317-2322 ◽  
Author(s):  
Michitaka Honda ◽  
Naoki Hiki ◽  
Souya Nunobe ◽  
Manabu Ohashi ◽  
Takashi Kiyokawa ◽  
...  
Keyword(s):  
Laparoscopic Surgery ◽  
Surgical Outcomes ◽  
Gastrointestinal Stromal Tumors ◽  
Stromal Tumors

Surgical Glove-port Single-incision Laparoscopic Gastric Wedge Resection of Gastrointestinal Stromal Tumors

2013 ◽  
Vol 23 (4) ◽  
pp. e160-e161 ◽  
Author(s):  
Erkinbek Orozakunov ◽  
Cihangir Akyol ◽  
Utku Tantoglu ◽  
Salim I. Basceken ◽  
Ilgaz S. Kayilioglu ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumors ◽  
Single Incision ◽  
Wedge Resection ◽  
Surgical Glove ◽  
Stromal Tumors ◽  
Glove Port

Long-term Survival among Patients with Gastrointestinal Stromal Tumors Diagnosed after Another Malignancy: A SEER Population-Based Study

2020 ◽  
Author(s):  
Chaoyong Shen ◽  
Chengshi Wang ◽  
Tao He ◽  
Zhaolun Cai ◽  
Xiaonan Yin ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumors ◽  
Population Based ◽  
Clinicopathological Characteristics ◽  
Second Primary ◽  
Primary Malignancy ◽  
Clinicopathologic Characteristics ◽  
Term Survival ◽  
Stromal Tumors ◽  
Group A

Abstract BACKGROUND: To explore overall survival (OS) and GISTs-specific survival (GSS) among cancer survivors developing a second primary gastrointestinal stromal tumors (GISTs). METHODS: We conducted a cohort study, where patients with GISTs after another malignancy (AM-GISTs, n=851) and those with only GISTs (GISTs-1, n=7660) were identified from the Surveillance, Epidemiology, End Results registries (1988-2016). Clinicopathologic characteristics and survival were compared between the two groups. RESULTS: The most commonly diagnosed first primary malignancy was prostate cancer (27.7%), followed by breast cancer (16.2%). OS among AM-GISTs was significantly inferior to that of GISTs-1: 10-year OS was 40.3% vs. 50.0%, (p<0.001); A contrary finding was observed for GSS (10-year GSS: 68.9% vs. 61.8%, p=0.002). In the AM-GISTs group, a total of 338 patients died, of which 26.0% died of their initial cancer and 40.8% died of GISTs. Independent of demographics and clinicopathological characteristics, mortality from GISTs among AM-GISTs patients was decreased compared with their GISTs-1 counterparts (HR, 0.71; 95% CI, 0.59-0.84; p<0.001); whereas OS was inferior among AM-GISTs (HR, 1.11; 95% CI, 0.99-1.25; p=0.085). CONCLUSIONS: AM-GISTs patients have decreased risk of dying from GISTs compared with GIST-1. Although another malignancy history does not seemingly affect OS for GISTs patients, clinical treatment of such patients should be cautious.

scholarly journals Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results

JAMA Oncology ◽  
2017 ◽  
Vol 3 (7) ◽  
pp. 944 ◽  
Author(s):  
Michael C. Heinrich ◽  
Cathryn Rankin ◽  
Charles D. Blanke ◽  
George D. Demetri ◽  
Ernest C. Borden ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Gastrointestinal Stromal Tumors ◽  
Long Term Results ◽  
Next Generation ◽  
Stromal Tumors ◽  
Generation Sequencing
Sign in / Sign up

Export Citation Format

Share Document